InvestSMART

Healius Limited (ASX: HLS) - Announcements

Current share price for HLS : $0.455 0.005 (1.09%)+

ASX company news and announcements for Healius Limited (HLS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Healius Limited (HLS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Healius Limited (HLS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Healius Limited (HLS)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$330 Change of Director's Interest Notice 14 Sep 2023 2:07PM $2.445 $0.455 fallen by 81.39%
$330 ACL: Update on offer for Healius and postponement of EGM 14 Sep 2023 8:16AM $2.390 $0.455 fallen by 80.96%
$330 Change of Director's Interest Notice 6 Sep 2023 4:53PM $2.690 $0.455 fallen by 83.09%
$330 Change of Director's Interest Notice 6 Sep 2023 4:51PM $2.690 $0.455 fallen by 83.09%
$330 Change of Director's Interest Notice 6 Sep 2023 4:50PM $2.690 $0.455 fallen by 83.09%
$330 Change of Director's Interest Notice 6 Sep 2023 4:50PM $2.690 $0.455 fallen by 83.09%
$330 2023 Annual General Meeting Information 6 Sep 2023 9:54AM $2.770 $0.455 fallen by 83.57%
$330 Change of Director's Interest Notice 6 Sep 2023 9:52AM $2.770 $0.455 fallen by 83.57%
$330 Change of Director's Interest Notice 6 Sep 2023 9:48AM $2.770 $0.455 fallen by 83.57%
$330 Application for quotation of securities - HLS 5 Sep 2023 1:02PM $2.790 $0.455 fallen by 83.69%
$330 Supplementary Target's Statement 5 Sep 2023 9:28AM $2.820 $0.455 fallen by 83.87%
$330 Application for quotation of securities - HLS 4 Sep 2023 9:55AM $2.780 $0.455 fallen by 83.63%
$330 Initial Director's Interest Notice 1 Sep 2023 10:53AM $2.780 $0.455 fallen by 83.63%
$330 HLS FY 2023 Results Presentation 30 Aug 2023 8:34AM $2.710 $0.455 fallen by 83.21%
$330 HLS Media Release FY 2023 Results 30 Aug 2023 8:28AM $2.710 $0.455 fallen by 83.21%
$330 Preliminary Final Report 30 Aug 2023 8:26AM $2.710 $0.455 fallen by 83.21%
$330 Change in substantial holding 17 Aug 2023 4:02PM $2.900 $0.455 fallen by 84.31%
$330 Becoming a substantial holder 9 Aug 2023 10:17AM $2.925 $0.455 fallen by 84.44%
$330 Webcast details for Healius FY 2023 Results 31 Jul 2023 4:27PM $2.870 $0.455 fallen by 84.15%
$330 Change in substantial holding from PPT 24 Jul 2023 4:14PM $2.950 $0.455 fallen by 84.58%
$330 ACCC Statement of Issues 20 Jul 2023 3:48PM $2.895 $0.455 fallen by 84.28%
$330 ACL: Takeover bid for Healius Ltd- extension of offer period 20 Jul 2023 2:09PM $2.905 $0.455 fallen by 84.34%
$330 AXX: ACL's proposed acquisition of Healius raises concerns 20 Jul 2023 9:56AM $2.870 $0.455 fallen by 84.15%
$330 Appointment of Dr Michael Stanford as a Non-Executive Direct 19 Jul 2023 9:18AM $2.850 $0.455 fallen by 84.04%
$330 Application for quotation of securities - HLS 4 Jul 2023 8:49AM $3.130 $0.455 fallen by 85.46%

326 - 350 of 1044 results

Page 14 of 42

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.